The global new medical biomaterials market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for biocompatible materials in the medical industry and rising awareness about the benefits of using these materials in various applications.
Metallic material segment accounted for the largest share of this market in 2018, followed by polymer materials segment. The polymer materials segment is expected to grow at a CAGR of 6% during the forecast period, owing to its wide range of applications and low cost compared with other biomaterials types.
Some Of The Growth Factors Of This Market:
- The global population is aging and the number of people with chronic diseases is increasing.
- There are new medical biomaterials that can be used to treat a variety of conditions, such as diabetes, cancer, and cardiovascular disease.
- New medical biomaterials are being developed to address unmet needs in the treatment of chronic diseases.
- New medical biomaterials have been shown to be more effective than traditional treatments.
Industry Growth Insights published a new data on “New Medical Biomaterials Market”. The research report is titled “New Medical Biomaterials Market research by Types (Metallic Material, Bio-ceramic, Polymer Materials, Composites, Others), By Applications (Packaging, Transplant components, Dental products, Catheters, Other), By Players/Companies Invibio, STR, Avitus, Sagemax, Stratasys, Formlab, TeraPore Technologies, NanoH2O (LG), Secant Medical, Covalent-coating, Nasseo, TriboFilm, ACS material, Palmaz Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
New Medical Biomaterials Market Research Report
By Type
Metallic Material, Bio-ceramic, Polymer Materials, Composites, Others
By Application
Packaging, Transplant components, Dental products, Catheters, Other
By Companies
Invibio, STR, Avitus, Sagemax, Stratasys, Formlab, TeraPore Technologies, NanoH2O (LG), Secant Medical, Covalent-coating, Nasseo, TriboFilm, ACS material, Palmaz Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global New Medical Biomaterials Market Report Segments:
The global New Medical Biomaterials market is segmented on the basis of:
Types
Metallic Material, Bio-ceramic, Polymer Materials, Composites, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Packaging, Transplant components, Dental products, Catheters, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Invibio
- STR
- Avitus
- Sagemax
- Stratasys
- Formlab
- TeraPore Technologies
- NanoH2O (LG)
- Secant Medical
- Covalent-coating
- Nasseo
- TriboFilm
- ACS material
- Palmaz Scientific
Highlights of The New Medical Biomaterials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metallic Material
- Bio-ceramic
- Polymer Materials
- Composites
- Others
- By Application:
- Packaging
- Transplant components
- Dental products
- Catheters
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the New Medical Biomaterials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
New medical biomaterials are materials that have been specifically designed to be used in medical procedures. These materials can be used to help heal wounds, repair organs, and support other body parts.
Some of the key players operating in the new medical biomaterials market are Invibio, STR, Avitus, Sagemax, Stratasys, Formlab, TeraPore Technologies, NanoH2O (LG), Secant Medical, Covalent-coating, Nasseo, TriboFilm, ACS material, Palmaz Scientific.
The new medical biomaterials market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. New Medical Biomaterials Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. New Medical Biomaterials Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. New Medical Biomaterials Market - Supply Chain
4.5. Global New Medical Biomaterials Market Forecast
4.5.1. New Medical Biomaterials Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. New Medical Biomaterials Market Size (000 Units) and Y-o-Y Growth
4.5.3. New Medical Biomaterials Market Absolute $ Opportunity
5. Global New Medical Biomaterials Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. New Medical Biomaterials Market Size and Volume Forecast by Type
5.3.1. Metallic Material
5.3.2. Bio-ceramic
5.3.3. Polymer Materials
5.3.4. Composites
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global New Medical Biomaterials Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. New Medical Biomaterials Market Size and Volume Forecast by Application
6.3.1. Packaging
6.3.2. Transplant components
6.3.3. Dental products
6.3.4. Catheters
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global New Medical Biomaterials Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. New Medical Biomaterials Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global New Medical Biomaterials Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. New Medical Biomaterials Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global New Medical Biomaterials Demand Share Forecast, 2019-2026
9. North America New Medical Biomaterials Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America New Medical Biomaterials Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America New Medical Biomaterials Market Size and Volume Forecast by Application
9.4.1. Packaging
9.4.2. Transplant components
9.4.3. Dental products
9.4.4. Catheters
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America New Medical Biomaterials Market Size and Volume Forecast by Type
9.7.1. Metallic Material
9.7.2. Bio-ceramic
9.7.3. Polymer Materials
9.7.4. Composites
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America New Medical Biomaterials Demand Share Forecast, 2019-2026
10. Latin America New Medical Biomaterials Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America New Medical Biomaterials Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America New Medical Biomaterials Market Size and Volume Forecast by Application
10.4.1. Packaging
10.4.2. Transplant components
10.4.3. Dental products
10.4.4. Catheters
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America New Medical Biomaterials Market Size and Volume Forecast by Type
10.7.1. Metallic Material
10.7.2. Bio-ceramic
10.7.3. Polymer Materials
10.7.4. Composites
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America New Medical Biomaterials Demand Share Forecast, 2019-2026
11. Europe New Medical Biomaterials Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe New Medical Biomaterials Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe New Medical Biomaterials Market Size and Volume Forecast by Application
11.4.1. Packaging
11.4.2. Transplant components
11.4.3. Dental products
11.4.4. Catheters
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe New Medical Biomaterials Market Size and Volume Forecast by Type
11.7.1. Metallic Material
11.7.2. Bio-ceramic
11.7.3. Polymer Materials
11.7.4. Composites
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe New Medical Biomaterials Demand Share, 2019-2026
12. Asia Pacific New Medical Biomaterials Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific New Medical Biomaterials Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific New Medical Biomaterials Market Size and Volume Forecast by Application
12.4.1. Packaging
12.4.2. Transplant components
12.4.3. Dental products
12.4.4. Catheters
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific New Medical Biomaterials Market Size and Volume Forecast by Type
12.7.1. Metallic Material
12.7.2. Bio-ceramic
12.7.3. Polymer Materials
12.7.4. Composites
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific New Medical Biomaterials Demand Share, 2019-2026
13. Middle East & Africa New Medical Biomaterials Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa New Medical Biomaterials Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa New Medical Biomaterials Market Size and Volume Forecast by Application
13.4.1. Packaging
13.4.2. Transplant components
13.4.3. Dental products
13.4.4. Catheters
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa New Medical Biomaterials Market Size and Volume Forecast by Type
13.7.1. Metallic Material
13.7.2. Bio-ceramic
13.7.3. Polymer Materials
13.7.4. Composites
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa New Medical Biomaterials Demand Share, 2019-2026
14. Competition Landscape
14.1. Global New Medical Biomaterials Market: Market Share Analysis
14.2. New Medical Biomaterials Distributors and Customers
14.3. New Medical Biomaterials Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Invibio
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. STR
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Avitus
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sagemax
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Stratasys
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Formlab
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. TeraPore Technologies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. NanoH2O (LG)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Secant Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Covalent-coating
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nasseo
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. TriboFilm
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. ACS material
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Palmaz Scientific
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
